TA ASSOCIATES, L.P.

TA Associates, L.P. is a Boston-based private equity and growth equity firm with one of the longest and most distinguished track records in growth investing, having pioneered the growth equity strategy since its founding in 1968. Filing quarterly 13F reports with the SEC under CIK #0001034569, TA Associates provides transparency into public equity positions held across its investment platform, which predominantly focuses on private growth equity and buyout investments in profitable, growing companies. Founded by C. Kevin Landry, who continues to serve as Chairman, TA Associates has invested in over 560 companies across its history, establishing itself as one of the leading growth-oriented private equity firms globally. The leadership team includes Managing Director and CEO Hythem El-Nazer, who directs overall firm strategy and operations, alongside Managing Directors P. Andrews McLane and Michael Hanson, who oversee investment activities and portfolio management across the platform's diverse sector focuses. This experienced partnership structure reflects TA's institutional approach to growth investing, with deep sector specialization across technology, healthcare, financial services, business services, and consumer industries. The firm's Boston headquarters positions it within one of America's premier private equity and venture capital ecosystems, providing access to talent, deal flow, and the concentration of institutional investors characterizing the region. TA Associates operates at a distinctive position within the private equity spectrum, focusing primarily on growth equity investments in profitable, established companies rather than early-stage venture capital or traditional leveraged buyouts. This growth equity orientation emphasizes partnerships with management teams building scaled businesses, often taking minority stakes enabling company ownership to benefit from growth alongside TA's capital and strategic value-add. The firm's 13F disclosures reveal public equity positions that typically represent companies initially invested in during private stages that subsequently completed IPOs, maintaining TA's exposure through public market transitions, or strategic public equity positions complementing the core private investment mandate.

TA Associates pursues a growth equity investment strategy targeting profitable, growing companies in the $20 million to $100 million-plus EBITDA range, providing expansion capital, facilitating ownership transitions, or supporting strategic initiatives including acquisitions, international expansion, or product development. The investment approach emphasizes partnering with proven management teams operating businesses with demonstrated product-market fit, recurring revenue models, strong unit economics, and clear paths toward continued growth and value creation. Unlike early-stage venture capital accepting losses while seeking home runs, TA focuses on established businesses with validated models requiring capital and strategic support to accelerate growth trajectories. The 13F Portfolio Composition reveals public equity positions representing a subset of TA's overall investment activities, as the majority of capital deploys into private companies not subject to quarterly disclosure requirements. Disclosed positions may include portfolio companies that have completed initial public offerings while TA maintains equity ownership, strategic stakes in publicly-traded businesses where the firm identifies value or strategic relevance, or transitional holdings during exit processes as positions migrate from private to public ownership. Understanding TA's disclosed holdings requires context about the firm's broader private equity mandate where 13F positions represent partial visibility. Sector Allocation History observable through quarterly 13F filings would demonstrate diversification across TA's core focus sectors including technology (software, internet, fintech), healthcare (healthcare IT, services, life sciences tools), financial services (payments, insurance, specialty finance), business services, and consumer sectors. The firm's sector specialization approach assigns dedicated investment teams with deep industry expertise to each focus area, enabling differentiated sourcing, due diligence capabilities, and value creation support through industry-specific knowledge and relationships. This sector focus differs from generalist approaches, instead building repeatable expertise and network effects within defined industry verticals. Investment thesis development emphasizes identifying companies with sustainable competitive advantages including technology differentiation, network effects, switching costs, regulatory barriers, or brand equity supporting durable market positions. Growth equity targets typically demonstrate strong revenue growth trajectories (often 20%+ annually), expanding or sustainable margins, capital-efficient business models, and opportunities for continued expansion through geographic penetration, product line extension, or market share gains. The profitability focus distinguishes TA's approach from venture capital strategies funding pre-revenue or unprofitable companies, instead emphasizing businesses with proven unit economics requiring capital to accelerate already-successful models. Portfolio construction balances sector diversification, vintage year spacing across economic cycles, stage diversification from pure growth equity through growth buyouts to traditional control buyouts, and geographic exposure spanning North America, Europe, and Asia. Top 10 Holdings Concentration in 13F disclosures may reveal significant positions in specific publicly-traded names representing TA's most successful companies that reached public markets, though interpretation requires recognizing these positions as only one component of broader private equity portfolios. Typical holding periods span four to seven years from initial investment through exit, with value creation pathways including organic growth, operational improvements, strategic acquisitions, and eventual realization through strategic sales, sponsor-to-sponsor transfers, or IPOs.

TA Associates, L.P. represents one of the pioneering and most established growth equity firms, applying over five decades of experience to investing in profitable, growing businesses across technology, healthcare, financial services, and other sectors. The Boston-based platform led by Founder C. Kevin Landry and Managing Director/CEO Hythem El-Nazer manages multiple fund vehicles deploying capital into minority and control growth equity investments. Quarterly 13F filings under CIK #0001034569 provide transparency into public equity positions representing companies transitioned to public markets or strategic public holdings, though these disclose only a subset of total private equity activities. For institutional allocators evaluating growth equity strategies, Historical Track Record assessment requires examining private fund performance across multiple vintage years rather than relying on 13F-disclosed public positions. Annualized Return (CAGR) calculations based on disclosed holdings would miss the majority of value creation occurring through private company appreciation and exit events outside public market visibility. The growth equity mandate positions TA investments between venture capital's early-stage risk profile and traditional buyout's mature business characteristics, targeting an attractive risk-return balance through profitable, growing companies. Key analytical considerations include understanding TA's sector expertise and dedicated industry team structure enabling differentiated sourcing and value creation, evaluating the firm's track record across economic cycles and exit environments, and assessing how the profitable growth equity strategy performs relative to unprofitable venture capital and cash-generative buyout alternatives. Sector Allocation History observable through 13F filings provides partial insight into sector positioning within public markets, though the majority of sector exposure resides in private holdings. Top 10 Holdings Concentration in disclosed positions may reveal significant stakes in notable companies representing TA's most successful investments reaching public markets. Sharpe Ratio and traditional volatility metrics provide limited relevance for private equity strategies given illiquid holdings, quarterly valuations, and return generation through multi-year value creation rather than trading or market timing. More relevant performance measures include internal rates of return (IRR), total value to paid-in capital (TVPI) multiples, and distributions to paid-in capital (DPI) demonstrating realized versus unrealized returns. The growth equity focus theoretically provides downside protection through profitable business models while maintaining upside participation through revenue growth and multiple expansion. Investment access depends on institutional investor qualifications and fund availability, as established private equity firms like TA typically maintain consistent limited partner bases across sequential fund vintages with limited new investor capacity. The firm's pioneering role in growth equity and extensive track record provides pattern recognition advantages and market positioning benefits in competitive deal environments. How would TA Associates' growth equity portfolio—emphasizing profitable but rapidly growing companies often trading near-term profitability for growth investment—perform through a prolonged period of elevated interest rates, compressed growth multiples, and investor preference for immediate cash generation over reinvestment for growth, where the core growth equity value proposition of funding profitable companies to accelerate expansion faces headwinds from both valuation compression and potential pressure from owners or boards to prioritize near-term profitability over growth investments central to the original investment theses?

TA Associates' risk profile reflects characteristics inherent in growth equity and private equity investing, including company-specific execution risk, illiquidity, valuation uncertainty, and economic cycle exposure affecting portfolio company growth trajectories and exit market conditions. Volatility Profile assessment differs meaningfully between private holdings valued quarterly through mark-to-model approaches and public positions subject to continuous market pricing. The growth equity focus on profitable, established businesses creates different risk characteristics compared to early-stage venture capital (higher failure rates, binary outcomes) or traditional leveraged buyouts (higher leverage, mature company cash flows). Execution risk represents fundamental exposure, as portfolio companies must successfully implement growth initiatives, navigate competitive dynamics, maintain management team stability, and execute operational plans supporting continued revenue and profitability expansion. Unlike mature, steady-state businesses characteristic of traditional buyouts, growth companies face ongoing challenges including market evolution, competitive responses to success, scaling organizational capabilities, and maintaining culture and execution quality through rapid headcount growth. Max Drawdown Depth considerations must account for private equity performance through economic downturns when revenue growth slows, valuation multiples compress, and exit markets become challenged. The profitable company focus provides downside protection compared to unprofitable growth businesses, as positive cash generation enables companies to weather temporary headwinds without facing existential funding crises. However, growth companies often trade current profitability for growth investment, creating sensitivity to capital availability and investor appetite for growth-oriented stories. The 2022-2023 technology reset demonstrated how quickly valuations can compress for growth businesses when interest rates rise, public market multiples contract, and investor preferences shift toward profitability over growth. Sector concentration across technology, healthcare, financial services, and business services creates exposure to industry-specific regulatory risks, technological disruption, and sector-wide valuation cycles. Technology investments face rapid innovation cycles, competitive intensity from well-capitalized incumbents and startups, and potential for product obsolescence. Healthcare exposure brings regulatory complexity, reimbursement uncertainties, and political risk surrounding healthcare costs and access. Financial services positions encounter regulatory oversight, fintech disruption, and macroeconomic sensitivity. Downside Capture Ratio analysis of public positions provides incomplete assessment of total private equity risk-return characteristics given the predominant focus on illiquid private holdings with different valuation methodologies and risk exposures. Public positions disclosed in 13F filings may demonstrate elevated volatility typical of growth-oriented stocks, particularly for recent IPOs experiencing post-listing price discovery and lock-up expiration dynamics. The minority investment approach common in growth equity creates governance limitations compared to control buyouts, relying on alignment and partnership with management rather than direct operational control. Exit market risk represents critical consideration, as private equity returns ultimately depend on realizing investments through sales or public listings at attractive valuations. IPO market closures, strategic buyer appetite fluctuations, and sponsor-to-sponsor market dynamics create timing uncertainties and valuation risks that can materially impact fund-level returns. The growth equity focus means portfolio companies may require additional capital rounds or extended hold periods if growth trajectories disappoint or exit markets prove unreceptive, creating J-curve extensions and delayed return realization.